{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T19:54:44Z","timestamp":1785873284582,"version":"3.56.0"},"reference-count":38,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2015,5]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Eosinophilic oesophagitis (EoE) is a growing cause of dysphagia. Current therapies include dietary manipulation, steroids and biological drugs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>To perform a systematic review and summarise the effect of different medical interventions on EoE.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Two reviewers searched Pubmed and Embase for studies on treatment for EoE. We included randomised controlled trials (\n                      <jats:styled-content style=\"fixed-case\">RCT<\/jats:styled-content>\n                      ) limited to pharmacological interventions. Two reviewers selected studies. Meta\u2010analysis was done using random effects model to estimate odds ratio (\n                      <jats:styled-content style=\"fixed-case\">OR<\/jats:styled-content>\n                      ). Heterogeneity was determined by Cochran's\n                      <jats:italic>Q<\/jats:italic>\n                      statistic and\n                      <jats:italic>I<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Seventeen references met our inclusion criteria. Eleven\n                      <jats:styled-content style=\"fixed-case\">RCT<\/jats:styled-content>\n                      s involving 455 participants were included in the meta\u2010analysis. 325 participants were evaluated for symptomatic improvement and 330 were evaluated for histological remission. Symptomatic improvement with topical steroids (7 studies, 250 participants) compared to the control group (placebo or\n                      <jats:styled-content style=\"fixed-case\">PPI<\/jats:styled-content>\n                      ) was noted (\n                      <jats:styled-content style=\"fixed-case\">OR<\/jats:styled-content>\n                      : 3.03, 95% confidence interval,\n                      <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>\n                      : 1.57\u20135.87). Histological remission was also noted in nine studies involving 330 participants (\n                      <jats:styled-content style=\"fixed-case\">OR<\/jats:styled-content>\n                      : 13.66, 95%\n                      <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>\n                      : 2.65\u201370.34) comparing topical steroids to a control (placebo or\n                      <jats:styled-content style=\"fixed-case\">PPI<\/jats:styled-content>\n                      ). There was no difference between anti\u2010\n                      <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\n                      \u20105 drugs and placebo in terms of symptomatic improvement (\n                      <jats:styled-content style=\"fixed-case\">OR<\/jats:styled-content>\n                      : 0.69, 95%\n                      <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>\n                      : 0.34\u20131.42).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Topical steroids induce significant symptomatic and histological remission, and should be considered as a first line treatment. Anti\u2010\n                      <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\n                      \u20105 therapy has a minor effect on eosinophilic oesophagitis. Future research in eosinophilic oesophagitis should standardise methodology according to published guidelines to improve quality and allow direct comparison between therapies.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/apt.13147","type":"journal-article","created":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T21:50:50Z","timestamp":1425246650000},"page":"797-806","source":"Crossref","is-referenced-by-count":69,"title":["Systematic review with meta\u2010analysis: pharmacological interventions for eosinophilic oesophagitis"],"prefix":"10.1111","volume":"41","author":[{"given":"T.","family":"Sawas","sequence":"first","affiliation":[{"name":"Department of Gastroenterology Medical College of Wisconsin Milwaukee WI USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Dhalla","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology Department of Medicine The Johns Hopkins School of Medicine Baltimore MD USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Sayyar","sequence":"additional","affiliation":[{"name":"Department of Medicine Medstar Washington Hospital Center Washington DC USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. J.","family":"Pasricha","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology Department of Medicine The Johns Hopkins School of Medicine Baltimore MD USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Hernaez","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology Department of Medicine The Johns Hopkins School of Medicine Baltimore MD USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,3]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2013.71"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2007.08.017"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2011.02.040"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2011.01.012"},{"issue":"3","key":"e_1_2_8_6_1","first-page":"CD004065","article-title":"Non\u2010surgical interventions for eosinophilic esophagitis","author":"Elliott EJ","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.02.006"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12438"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12332"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2009.06.005"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d5928"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00455-009-9246-8"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2011.11.044"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2014.05.021"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2010.05.001"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2012.04.049"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2012.03.018"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.04.019"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.05.036"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2009.178558"},{"key":"e_1_2_8_21_1","doi-asserted-by":"crossref","first-page":"S235","DOI":"10.1016\/S0016-5085(11)60951-7","article-title":"A pilot study of the treatment of eosinophilic esophagitis with omalizumab","volume":"140","author":"Fang JC","year":"2011","journal-title":"Gastroenterology"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2012.443"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2011.01.017"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-009-0859-4"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2006.08.033"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2007.11.008"},{"key":"e_1_2_8_27_1","doi-asserted-by":"crossref","first-page":"S147","DOI":"10.1016\/S0016-5085(12)60552-6","article-title":"Treatment of eosinophilic esophagitis with the CRTH2\u2010antagonist oc000459: a novel therapeutic principle","volume":"142","author":"Straumann A","year":"2012","journal-title":"Gastroenterology"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(14)60055-X"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2010.07.048"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2009.06.023"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2010.04.009"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2010.09.037"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.gtc.2014.02.015"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2003.09.024"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2000.02073.x"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1542-3565(05)00885-2"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0b013e31817f0197"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12413"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.08.028"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fapt.13147","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/apt.13147","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T04:40:42Z","timestamp":1696480842000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/apt.13147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":38,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["10.1111\/apt.13147"],"URL":"https:\/\/doi.org\/10.1111\/apt.13147","archive":["Portico"],"relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.725372300.793536882","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.725372300.793505419","asserted-by":"object"}]},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3]]}}}